Sequoia Financial Advisors LLC Grows Stock Holdings in Haleon plc (NYSE:HLN)

Sequoia Financial Advisors LLC lifted its position in shares of Haleon plc (NYSE:HLN) by 2.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 85,690 shares of the company’s stock after purchasing an additional 2,101 shares during the period. Sequoia Financial Advisors LLC’s holdings in Haleon were worth $814,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the company. HighTower Advisors LLC lifted its position in shares of Haleon by 3.4% during the 4th quarter. HighTower Advisors LLC now owns 362,685 shares of the company’s stock worth $3,460,000 after purchasing an additional 11,890 shares during the last quarter. Natural Investments LLC purchased a new stake in shares of Haleon during the 4th quarter worth $840,000. King Luther Capital Management Corp raised its stake in Haleon by 27.8% during the 4th quarter. King Luther Capital Management Corp now owns 19,063 shares of the company’s stock worth $182,000 after acquiring an additional 4,148 shares in the last quarter. Independent Advisor Alliance raised its stake in Haleon by 78.8% during the 4th quarter. Independent Advisor Alliance now owns 27,323 shares of the company’s stock worth $261,000 after acquiring an additional 12,044 shares in the last quarter. Finally, Dorsey & Whitney Trust CO LLC raised its stake in Haleon by 14.7% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 31,027 shares of the company’s stock worth $296,000 after acquiring an additional 3,984 shares in the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Finally, HSBC reiterated a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Six research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Haleon currently has a consensus rating of “Hold” and a consensus price target of $10.95.

Haleon Trading Down 0.3 %

NYSE HLN opened at $10.16 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The firm has a market cap of $45.97 billion, a PE ratio of 29.87, a P/E/G ratio of 2.82 and a beta of 0.25. Haleon plc has a one year low of $7.89 and a one year high of $10.80. The firm’s fifty day moving average is $9.75 and its two-hundred day moving average is $9.87.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The company had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. Analysts expect that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The company also recently announced a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. This is an increase from Haleon’s previous — dividend of $0.05. The ex-dividend date is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon’s payout ratio is presently 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.